OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Orthofix Medical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$9.59+0.21 (+2.24%)
Close on Oct 19, 2026
- Market cap
- $392.29M
- P/E (TTM)
- –
- Dividend yield
- –
Orthofix Medical Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Spine [Member] | $687.66M | $675.31M | $631.32M | $353.17M | $358.96M | $321.74M | $357.22M | $346.59M | $330.58M | – | 83.6% | +1.8% |
| Global Limb Reconstruction [Member] | $134.66M | $124.18M | $115.32M | – | – | – | – | – | – | – | 16.4% | +8.4% |
| Spine Fixation [Member] | – | – | – | – | – | – | – | – | $81.96M | $72.63M | – | – |
| Extremity Fixation [Member] | – | – | – | – | – | – | – | – | $103.24M | $102.68M | – | – |
| Biologics [Member] | – | – | – | $56.38M | $56.42M | $55.48M | $65.50M | $59.68M | $62.72M | $57.91M | – | – |
| BioStim [Member] | – | – | – | – | – | – | – | – | $185.90M | $176.56M | – | – |
| Orthofix Extremities [Member] | – | – | – | – | – | – | – | $106.45M | $103.24M | $102.68M | – | – |
| Spinal Implants [Member] | – | – | – | $109.55M | $115.09M | $94.86M | $94.54M | $91.66M | $81.96M | $72.63M | – | – |
| Bone Growth Therapies [Member] | – | – | – | $187.25M | $187.45M | $171.40M | $197.18M | $195.25M | $185.90M | $176.56M | – | – |
| Global Extremities [Member] | – | – | – | – | – | $84.83M | $102.73M | $106.45M | $103.24M | – | – | – |
| Global Orthopedics [Member] | – | $124.18M | $115.32M | $107.54M | $105.52M | $84.83M | $102.73M | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M6-L Artificial Lumbar Disc [Member] | – | $23.40M | – | – | – | – | – | – | – | – | – | – |
| M6-C Artificial Cervical Disc [Member] | – | $23.40M | – | – | – | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $684.07M | $672.82M | $620.83M | $358.84M | $361.95M | $327.28M | $361.94M | $355.35M | $345.15M | $316.87M | 83.2% | +1.7% |
| International [Member] | $138.25M | $126.68M | $125.81M | $101.87M | $102.53M | $79.28M | $98.02M | $97.69M | $88.68M | $92.92M | 16.8% | +9.1% |
| Others [Member] | $76.73M | $66.40M | $65.83M | $44.99M | $42.50M | $30.76M | $39.25M | $50.90M | $45.48M | $48.11M | 9.3% | +15.6% |
| Italy | $22.28M | $21.00M | $20.06M | $19.10M | $20.19M | $18.73M | $19.56M | $19.33M | $17.06M | $16.66M | 2.7% | +6.1% |
| United Kingdom | $13.33M | $11.18M | $10.91M | $10.17M | $10.55M | $7.15M | $10.09M | $8.73M | $8.73M | $10.36M | 1.6% | +19.2% |
| France | $11.96M | $13.39M | $11.10M | $10.38M | $10.48M | $8.35M | $8.75M | – | – | – | 1.5% | -10.7% |
| Germany | $9.11M | $9.00M | $11.47M | $11.57M | $13.72M | $11.94M | $12.69M | $11.61M | $7.06M | $6.45M | 1.1% | +1.1% |
| Brazil | $4.84M | $5.71M | $6.45M | $5.67M | $5.11M | $2.35M | $7.69M | $7.12M | $10.36M | $11.33M | 0.6% | -15.3% |
| Customers and Distributors Based in Europe [Member] | – | – | – | – | – | $57.70M | $69.00M | $69.00M | $57.00M | $60.00M | – | – |
From the segment and revenue-disaggregation notes of Orthofix Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.